Evidence map›Paper›PMID 31541608›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2020

Allicin Reversed the Process of Frailty in Aging Male Fischer 344 Rats With Osteoporosis.

Yang Liu, Meigui You, Jianwei Shen, Yaping Xu, Lin Li, Dongtao Wang, Yajun Yang

Abstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Frailty Risk Prediction Model among Older Adults: A Chinese Nation-Wide Cross-Sectional Study.International journal of environmental research and public health · 2022
    Article
  6. Review
  7. Review
  8. Review
  9. Longitudinal Bone Growth Stimulating Effect ofMolecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yang LiuDepartment of Basic Nursing, Harbin Medical University, Daqing, China.
Meigui YouXiamen Medical College, China.
Jianwei ShenDepartment of Bone Surgery, Daqing People's Hospital, China.
Yaping XuXiamen Medical College, China.
Lin LiGuangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, China.
Dongtao WangDepartment of Traditional Chinese Medicine, Shenzhen Hospital, Southern Medical University, China.
Yajun YangDepartment of Pharmacology, Guangdong Key Laboratory for R&D of Natural Drugs, Guangdong Medical University, Zhanjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The research and development of pharmaceutical intervention is insufficient for the frail older adults, especially in preclinical stage for the frail individuals with osteoporosis. Garlic exerts an antiosteoporotic effect and its vital component allicin could protect organisms against aging. The present study aimed to investigate the effect of long-term intragastric administration of allicin (low dose of 4 mg·kg-1·d-1; middle dose of 8 mg·kg-1·d-1; high dose of 16 mg·kg-1·d-1) on frailty with osteoporosis in aging male Fischer 344 rats. Frailty was assessed with a 27-item frailty index based on quantifying health-related deficits in adult male rats varied from 13 to 21 months and in control rats from 6 to 9 months. Osteoporosis was appraised by bone mineral density detected by dual-energy X-ray absorptiometry, biomechanical properties measured by a three-point bending test, and bone metabolic analysis using ELISA. Allicin could attenuate frailty index scores by reducing the accumulation of health deficits in aging male Fischer 344 rats. Meanwhile, allicin could protect against senile osteoporosis, and the underlying mechanism may involve in increasing low bone turnover through elevation of both bone formation and bone resorption, and subsequently lead to increase of bone mineral density, contributing to reversing deleterious bone biomechanical features associated with aging. The present study reveals firstly that long-term oral administration with allicin attenuated frailty with osteoporosis during the process of aging, which provides a preclinical evidence for intervention of frailty.

Indexed as

AgingAnimalsBone DensityBone RemodelingDisulfidesFrailtyMaleOsteoporosisRatsRats, Inbred F344Sulfinic AcidsallicinDisulfidesSulfinic AcidsAntiosteoporosis effectFrailty indexPharmaceutical intervention

Identifiers

PMID31541608
PMCPMC7164536

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.